Pruritus Therapeutics Market Pipeline Review, H2 2017
“Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline
Review, H2 2017, provides an overview of the Pruritus (Dermatology)
pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline Review, H2 2017, provides an
overview of the Pruritus (Dermatology) pipeline landscape.
Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused
by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps,
spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic,
asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Pruritus - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Pruritus (Dermatology), complete
with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Browse Detail Report With TOC @
https://www.hexareports.com/report/pruritus-pipeline-review-h2-2017
Follow Us: